Long-term Survivorship of Transfibular Trabecular Metal Total Ankle Arthroplasty: 10-Year Minimum Clinical and Radiographic Follow-up
Foot & Ankle International · 2026
DOI: 10.1177/10711007261471453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foot & Ankle International, 2026. Verfasst von Kevin A Schafer und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Foot and Ankle Surgery, Department of Orthopedic Surgery, NYU Langone Health, New York, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Ankle, Joint Prosthesis, Ankle Joint. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
Background
Total ankle arthroplasty (TAA) utilization has rapidly increased over the last decade despite relatively unknown long-term survivorship of fourth-generation implants. The purpose of this study was to determine the long-term survivorship of the trabecular metal (TM) transfibular TAA and report relevant interval changes.
Methods
Retrospective review was performed of prospectively followed patients who underwent primary transfibular TAA by a single surgeon from October 2012 to February 2016, including patients with minimum 10-year clinical and radiographic follow-up. Patient-reported outcomes measures (PROMs) included 12-item Short Form Health Survey physical (SF-12 PCS) and mental (SF-12 MCS) component summary scores, Ankle Osteoarthritis Scale (AOS), and visual analog scale (VAS). Radiographic outcomes included alignment, motion, presence of periprosthetic lucencies. Adverse events and reoperations were reported using the Canadian Orthopaedic Foot and Ankle Society (COFAS) Reoperation Coding System (CROCS).
Results
Seventy-one ankles (68 patients) were included out of 79 TAAs (89.9%) with mean age of 61 (range, 28-80) years. Mean follow-up was 11.0 years (IQR, 1.5). There was 1 metal component revision (MCR) for periprosthetic joint infection requiring below-knee amputation (CROCS 11). Twenty-nine (40.8%) ankles underwent reoperations, with no ankles requiring more than 3 reoperations. The most common indication for reoperation was gutter debridement (n = 12; CROCS 4). Five cysts were detected in 4 ankles (7%) at final follow-up. Postoperative PROMs, radiographic alignment and motion were stable between 5- and ≥10-year time points.
Conclusion
This single surgeon cohort demonstrated 98.6% implant survivorship of the TM transfibular TAA at a mean 11-year follow-up. Radiographic evaluation showed stable alignment and range of motion between midterm and long-term follow-up, and low rates of periprosthetic lucencies with minimal interval osteolysis between 5- and 10-year evaluations. Overall, these results support transfibular TAA as a durable long-term treatment for ankle arthritis. Level of Evidence: Level IV, case series.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Foot and Ankle Surgery, Department of Orthopedic Surgery, NYU Langone Health, New York, USA.
- Institute for Foot and Ankle Reconstruction at Mercy Medical Center, Baltimore, MD, USA.
ORCID-Profile: Kevin A Schafer, Jonathan Day, Katherine Convery, Zijun Zhang, Lew C Schon
Zitieren
APA
Schafer, K. A., Day, J., Convery, K., Zhang, Z., & Schon, L. C. (2026). Long-term Survivorship of Transfibular Trabecular Metal Total Ankle Arthroplasty: 10-Year Minimum Clinical and Radiographic Follow-up. Foot & Ankle International. https://doi.org/10.1177/10711007261471453
Vancouver
Schafer KA, Day J, Convery K, Zhang Z, Schon LC. Long-term Survivorship of Transfibular Trabecular Metal Total Ankle Arthroplasty: 10-Year Minimum Clinical and Radiographic Follow-up. Foot & Ankle International. 2026. doi:10.1177/10711007261471453
BibTeX
@article{Schafer2026,
author = {Schafer, Kevin A and Day, Jonathan and Convery, Katherine and Zhang, Zijun and Schon, Lew C},
title = {Long-term Survivorship of Transfibular Trabecular Metal Total Ankle Arthroplasty: 10-Year Minimum Clinical and Radiographic Follow-up},
journal = {Foot & Ankle International},
year = {2026},
doi = {10.1177/10711007261471453}
}
EUVIMED